Liver Cancer

In 2018, an estimated 3,714 Texans were diagnosed with liver & intrahepatic bile duct cancer. An estimated 2,532 Texans died from it. Liver & intrahepatic bile duct cancer is the sixth most common cause of cancer death in Texas.

Liver & intrahepatic bile duct cancer is associated with modifiable risk factors, including chronic hepatitis B virus or hepatitis C virus infections, liver cirrhosis, tobacco use, obesity, and diabetes. As many as 63% of cases can be attributed to modifiable risk factors.

In Texas, the incidence rate for this cancer in adults ages 25 years and older has significantly increased by an average of 3.9% per year. In 2001, the incidence rate was 9.3 cases per 100,000; it had increased to 16.6 cases per 100,000 in 2015. During the same time period, the US rate increased by an average of 3.8% per year. In 2015, Texas had the highest incidence rate and fourth highest mortality rate of all US states.

Liver & intrahepatic bile duct cancer has low survival. Compared to Texans without cancer, only 15.6% of Texans survive for five years after being diagnosed with liver & intrahepatic bile duct cancer.

This statistical report describes incidence and mortality rates for liver & intrahepatic bile duct cancer in Texas. It replicates some of the analyses described in a recent publication on trends in liver and intrahepatic bile duct cancer mortality in the United States.1 To quantify rates and trends of liver and intrahepatic bile duct cancers from 2001-2015, age-adjusted incidence and mortality rates were calculated for Texans ages 25 years and older by sex, age, and race/ethnicity.

The accompanying two-page summary shows information on liver & intrahepatic bile duct cancer incidence, mortality, risk factors, prevalence, and relative survival.

 

1 Xu, J. (2018). Trends in liver cancer mortality among adults aged 25 and over in the United States, 2000-2016. NCHS Data Brief, No.314.

 

Back to Cancer Statistics

 

 

Texas Cancer Registry

Texas Cancer Registry

Cancer Statistics